Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAKARO, T.
Right arrow Articles by MURPHY, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAKARO, T.
Right arrow Articles by MURPHY, J. D.
(Chest. 1955;28:203-216.)
© 1955 American College of Chest Physicians

The Treatment of Pulmonary Blastomycosis

TIMOTHY TAKARO M.D.1; JAMES E. T. HOPKINS M.D.1; and JAMES D. MURPHY M.D., F.C.C.P.1

1 The Veterans Administration Hospital, Oteen, North Carolina.

From this study, one can only conclude that a completely satisfactory form of treatment for pulmonary blastomycosis has not yet been found. Pulmonary resection for localized, stable lesions after immunological balance is obtained may be an important therapeutic aid. The use of undecylenic acid orally and of stilbarnidine or 2-hydroxystilbamidine intravenously are useful measures. Combined therapy with undecylenic acid and one of the diamidines may be the best method of drug treatment available.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1955 by the American College of Chest Physicians.